Clinical trial
Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes
NCT03195140 is registered in ClinicalTrials.gov with Tandem Diabetes Care, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes
- Lead sponsor
- Tandem Diabetes Care, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 11, 2017
- Completion date
- February 6, 2018
- Enrollment
- 103 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.